• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
WIN 55,212-2 Mesylate

WIN 55,212-2 Mesylate

Product ID W317520
Cas No. 131543-23-2
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $93.00 In stock
25 mg $178.90 In stock
100 mg $551.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

WIN 55,212-2 (WIN)is a potent, non-selective synthetic cannabinoid agonist. It shows activity in a variety of disease states. Recent work demonstrates the ability of WIN as a pain analgesic, anti-cancer and anti-Alzheimer’s compound. In studies using colon carcinoma cell lines, WIN decreases cell proliferation of colon cancer cells. Additionally WIN down-regulated protein phosphatase 2A, a different mechanism than other cannabinoid agonists. WIN also decreases the effects of Amyloid 1-42 effects on primary mouse astrocyte cell culture. WIN inhibits the over-expression of interleukin-1 and tumor necrosis factor-, common signs of A over expression. Additionally, in a murine pain model, WIN decreased the response to pain stiumuli in mouse models of cancer pain.

Product Info

Cas No.

131543-23-2

Purity

≥98%

Formula

C28H30N2O6S

Formula Wt.

522.61

Chemical Name

(R)-(+)-[2,3-Dihydro-5-methyl-3[(4-morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate salt

IUPAC Name

methanesulfonic acid;[(11R)-2-methyl-11-(morpholin-4-ylmethyl)-9-oxa-1-azatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraen-3-yl]-naphthalen-1-ylmethanone

Synonym

WIN 55212-2 methanesulfonate, WIN 552122 mesylate

Solubility

DMSO (12 mg/mL)

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

W317520 MSDS PDF

Info Sheet

W317520 Info Sheet PDF

References

Aquirre-Rueda D, Guerra-Ojeda S, Aldasoro M et al. WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid beta1-42 effects on astrocytes in primary culture. PLoS One. 2015 Apr 13;10(4):e0122843. PMID: 25874692.

Sreevalsan S, and Safe S. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells. Mol Cancer Ther. 2013 Nov;12(11):2483-93. PMID: 24030632.

Uhelski ML, Cain DM, Harding-Rose C, and Simone DA. The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer pain. Neuroscience. 2013 Sep 5; 247:84-94. PMID: 23673278.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • E7731

    17-α-Ethynylestradiol

    Synthetic steroid hormone; ER agonist.

    ≥99%
  • X0384

    XAV-939

    Tankyrase inhibitor.

    ≥98%
  • R0248

    Ramatroban

    CRTH2 inhibitor, TxA2 antagonist.

    ≥98%
  • E5241

    Met-Enkephalin

    Endogenous opioid peptide; δOR and μOR agonis...

    ≥95%
  • I7356

    Isopropyl Thiogalactoside

    Galactose analog, allolactose mimic, induces ac...

    ≥98%
  • A8070

    Auraptene

    Monoterpene coumarin ether found in Citrus; PPA...

    ≥98%
  • A2046

    Aflatoxin B2

    Mycotoxin produced by species of Aspergillus; D...

    ≥98%
  • L5870

    Lornoxicam

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • C0160

    Canrenone

    Metabolite of spironolactone; Na+/K+ ATPase par...

    ≥98%
  • T0298

    Tazobactam

    β-lactamase inhibitor.

    ≥98%
  • T5605

    Tobramycin Sulfate

    Aminoglycoside; protein translation inhibitor.<...

    ≥98%
  • Z161022

    α-Zearalanol

    Mycotoxin that has structural similarity to est...

    ≥98%
  • T0251

    Tamsulosin Hydrochloride

    α1-adrenergic antagonist.

    ≥98%
  • B6806

    Bradykinin (2-9)

    Natriuretic, vasodilatory peptide fragment; B1/...

    ≥95%
  • K7600

    KT5720

    PKA and PDK1 inhibitor, HCN channel blocker, po...

    ≥98%
  • A985134

    AZD-9291

    EGFR inhibitor.

    ≥99%
  • C6956

    Crotamiton

    Antipruritic.

    ≥98%
  • C1867

    Ceramide

    Endogenous sphingosine-based lipid, component of s...
    ≥98%
  • S822687

    Surfactin

    Amphiphilic properties

    ≥90% mixed isomers
  • Z161024

    α-Zearalenol

    Mycotoxin that has structural similarity to est...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only